Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Mark on +44 1494 818 049 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Mark Denton
Managing Director
+44 1494 818 049

Zenopa was very friendly, enthusiastic and encouraging as I searched for a new position. They listened attentively to my requirements.
Leonie, 2014

Kimberly-Clark sees year-on-year growth in first quarter

27 April 2010 00:00 in Pharmacy Supplier News

Kimberly-Clark has published its financial report for the first quarter of 2010, reporting a 7.6 per cent year-on-year increase in its net sales.

The company's sales for the three-month period grew to $4.8 billion (3.1 billion pounds), with the company's healthcare, personal care and consumer products divisions all seeing net sales growth.

In addition, the firm's acquisitions of I-Flow Corporation and Jackson Safety last year were also cited as having contributed to this quarter's improved sales performance.

Thomas Falk, chairman and chief executive officer, described the figures as a "solid start to the year".

He said: "We strengthened our brands by launching a number of innovations in the first quarter and by significantly increasing strategic marketing spending."

Last month, Kimberly-Clark revealed plans to launch a number of consumer health and hygiene products over the coming year, including new Poise and Depend incontinence offerings and a number of new additions to the Kotex feminine care brand.

Other news stories from 27/04/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd